Alberto Boccadoro (@a_boccadoro_md) 's Twitter Profile
Alberto Boccadoro

@a_boccadoro_md

If we have data, let’s look at data. If all we have are opinions, let’s go with mine.

ID: 1357070702164197376

calendar_today03-02-2021 20:57:36

63 Tweet

138 Followers

132 Following

NephroPOCUS (@nephrop) 's Twitter Profile Photo

Hairy heart: an illustrative #echofirst image of complex pericardial effusion. From this interesting 🧾🔗nejm.org/doi/full/10.10… Presumed uremic pericarditis #POCUS #MedEd #Nephpearls

Dr. Filippo Cademartiri (@fcademartiri) 's Twitter Profile Photo

STATE OF THE ART PHOTON COUNTING CT Functional assessment of LV/RV in Congenital Heart Diseases/ASD sinus venosus - Part II (RV) Ex. cine MPR 512x512 matrix (FOV 140mm) of LA of RV CTA images (source images 1.0/0.7mm; thickness/increment). Kernel Bv36. QIR level 4.

Antonella Scala (@antonellascl95) 's Twitter Profile Photo

Two birds with one stone and three valves with an exam! - Mosaic 25 mm for AV stenosis + aortic plastic sec Cotrufo -> prothesis dysfunction and rocking, aneurysm, hoematoma - Massive TR with septal leaflet incarceration by EC - Severe MR with A3 flail and A2 perforation

Luca Canovi (@luca_canovi_) 's Twitter Profile Photo

The MULTIMODALITY you don't expect. #echofirst 👩 51 y/o coming for abdominal discomfort and vomiting. PMH: Ascending Aortic Aneurysm being followed-up periodically. 1/4

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standard of care reduced MACE by 20% in 17,604 adults with established CVD with overweight or obesity and without prior history of diabetes. Let's wait for the NNT.

Breaking news from Novo Nordisk. In the randomized, double-blind SELECT trial, semaglutide 2.4 mg as an adjunct to standard of care reduced MACE by 20% in 17,604 adults with established CVD with overweight or obesity and without prior history of diabetes. Let's wait for the NNT.
Tebaldi Matteo (@tebaldi_matteo) 's Twitter Profile Photo

Today is like July 2006, I will wait for Simone Biscaglia presentation like Grosso's penalty, knowing that the team created by Gianluca Campo started as an underdog ,like Lippi's national team, to then reach the top of the world. ..... waiting for the FIRE Trial #ESC2023

Today is like July 2006, I will wait for   <a href="/SimoneBiscaglia/">Simone Biscaglia</a> presentation like Grosso's penalty, knowing that the team created by <a href="/GianlucaCampo78/">Gianluca Campo</a> started as an underdog ,like Lippi's national team, to then reach the top of the world. ..... waiting for the <a href="/theFIRE_trial/">FIRE Trial</a> #ESC2023
Antonella Scala (@antonellascl95) 's Twitter Profile Photo

Check out our latest investigation on the prognostic value of Syntax Score II 2020 corrected for flow-limiting lesions and its ability to better address treatment by benefit prediction among patients with left main or multivessel disease! mdpi.com/2077-0383/12/1…

Francesco Vitali (@fra_vitali90) 's Twitter Profile Photo

#Epeeps which is your favourite vascular access route for PM/ICD leads? Check out our randomized trial on ultrasound-guided axillary vein access on #JACCEP - ZEROFLUOROAXI TRIAL 💪💪Great team work from University of Ferrara 🇮🇹 #unife 👇👇 sciencedirect.com/science/articl…

MatteoBertini (@matteobertini5) 's Twitter Profile Photo

Comparative Study of Lesions Obtained through Radiofrequency between the Irrigated Ablation Catheter with a Flexibl… pubmed.ncbi.nlm.nih.gov/38392350/

Dr. Filippo Cademartiri (@fcademartiri) 's Twitter Profile Photo

STATE OF THE ART PHOTON COUNTING CT - What can CT do for you and your patients? 4D-VR and multi-axis MPR of severely degenerated and stenotic aortic valve (bicuspid; rare L-R). Ex. from axial 1024x1024 matrix; source images 0.2/0.1mm; thickness/increment. Kernel Bv48-60. QIR 4.

Gianluca Campo (@gianlucacampo78) 's Twitter Profile Photo

From 🇮🇹 to 🇬🇧 another step forward for a great team ... starting from our Professor Ferrari to our fellows... see you in 🇪🇸 Madrid 2025

From 🇮🇹 to 🇬🇧 another step forward for a great team ... starting from our Professor Ferrari to our fellows... see you in 🇪🇸 Madrid 2025